-
Nordic Pharma Celebrates 30th Anniversary
-This year, Nordic Pharma celebrates a significant milestone: 30 years of advancing patient safety, innovation, and purpose-driven work. Over the…
0 -
Nordic Pharma Awarded the Silver Medal by EcoVadis
-Nordic Pharma is proud to announce it has been awarded the Silver Medal by EcoVadis in August 2025. This accreditation…
-
Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch
-Hoofddorp, Netherlands, April 9th 2025 – Nordic Group B.V., an international pharmaceutical company operating as Nordic Pharma, announced today that…
-
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), CONTINUES ITS INTRODUCTION OF LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2024.
-Nordic Pharma to share this innovation and its pivotal study article in the Journal of Cataract and Refractive Surgery (JCRS)…
-
NORDIMET (methotrexate) Self-Injection Pen now available for Treatment of Rheumatoid Arthritis and Psoriasis/Psoriatic Arthritis in Canada
-Press Release Toronto, August 5, 2024 – Linepharma International Inc., a subsidiary of Nordic Group B.V. (NORDIC PHARMA), is pleased…
-
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES THE LAUNCH OF LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE.
-Nordic Pharma attending Kiawah Eye to share this innovation with ophthalmology leaders. BERWYN, PA – Nordic Pharma, Inc., a subsidiary…
-
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
-Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in…
-
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY AMRING PHARMACEUTICALS INC., ANNOUNCES JAI G. PAREKH, MD, MBA AS CHIEF COMMERCIAL OFFICER, EYE CARE U.S.
-BERWYN, PA — Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announces Jai G. Parekh, MD,…
-
NORDIC PHARMA GROUP B.V. THROUGH ITS SUBSIDIARY AMRING PHARMACEUTICALS INC., COMPLETES ACQUISITION OF VISANT MEDICAL TO LAUNCH NOVEL THERAPY FOR DRY EYE DISEASE IN THE UNITED STATES
-BERWYN, PA — Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today the completion of…
-
Nordic Pharma joins the Pharmaceutical Supply Chain Initiative
-We are pleased to announce that Nordic Pharma has joined the Pharmaceutical Supply Chain Initiative (PSCI) as an associate member…
